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GSK-3b is a basally active kinase. Axin forms a complex with GSK-3b and b-catenin; this complex pro-
motes the GSK-3b-dependent phosphorylation of b-catenin, thereby inducing its degradation. How-
ever, the inhibition of GSK-3b provokes cell migration via the dysregulation of b-catenin. In this
study, we determined that the level of apoptosis signal-regulating kinase 1 (ASK1) was lower in a
metastatic breast cancer cell line, compared to that of non-metastatic cancer cell lines and the
knockdown of ASK1 not only induces b-catenin activation via the inhibition of GSK-3b and collaps-
ing the subsequent protein complex by regulating Axin dynamics, but also stimulates cell migration.
Together, the blockage of the GSK-3b–b-catenin pathway resulting from the knockdown of ASK1
modulates the migration of breast cancer cells.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Apoptosis signal-regulating kinase 1 (ASK1), a serine-threonine
kinase, was initially discovered as a mitogen-activated protein ki-
nase kinase kinase (MAPKKK) in the c-Jun N-terminal kinase
(JNK) and p38 MAPK signaling pathways [1]. ASK1 induces apopto-
tic cell death via a mitochondria-dependent pathway related to
cytochrome c release and caspase 9 and caspase 3 activation [2].
ASK1 has also been implicated in various cellular events, including
differentiation, proliferation and innate immunity [3].
The serine/threonine kinase glycogen synthase kinase-3 (GSK-
3) was initially identiﬁed as a regulator of glycogen metabolism,
and has been shown to regulate a variety of cellular processes,
including apoptosis, differentiation, growth, motility and the epi-
thelial-mesenchymal transition (EMT) [4]. GSK-3 stabilizes Axin
via phosphorylation and maintains the formation of the Axin–
GSK-3b–b-catenin destruction complex [5–8]. This complex pro-
motes the GSK-3b-dependent phosphorylation of b-catenin, there-
by inducing the degradation of b-catenin [6,8]. However, Wnt
signaling disrupts the Axin–GSK-3b–b-catenin destruction com-
plex and induces the abnormal accumulation of b-catenin [9,10].
Free b-catenin then translocates to the nucleus, where it interacts
with T cell factor (TCF)/lymphoid enhancer-binding factor familychemical Societies. Published by Emembers to induce the expression of speciﬁc genes associated
with physiological events such as development, proliferation and
migration [11].
Here, we report that not only basal GSK-3b activity but also the
Axin–GSK-3b–b-catenin destruction complex regulated by ASK1
modulates b-catenin-mediated cancer cell migration in a GSK-3b-
dependent manner.
2. Materials and methods
2.1. Cell culture
MCF7 GFP, ASK1 siRNA cells were maintained in DMEM (Invit-
rogen, CA) supplemented with 10% fetal bovine serum, penicillin
(100 U/ml), and streptomycin (100 g/ml) in a humidiﬁed atmo-
sphere of 5% CO2 at 37 C.
2.2. RNAi
The ASK1 siRNA sequence, 50-GCACUCCUUCAUCGAGCUAUU-30
and the GFP siRNA sequence 50-CCUACGCCACCAAUUUCGU-30 siR-
NAs were synthesized by Bioneer (Daejeon, South Korea). pSU-
PERretropuro siRNA expression vector (Oligoengine, Inc.) was
used to construct an ASK1 siRNA plasmid. MCF7 Cells were tran-
siently transfected with a microporator (Digital Bio Technology,
Seoul, South Korea).lsevier B.V. All rights reserved.
Fig. 1. ASK1 is highly expressed in less metastatic breast cancer cell lines (MCF7,
SKBR3, MDA468) rather than metastatic breast cancer cell line (MDA231). Whole-
cell extracts were prepared from MDA231, MCF7, SKBR3 and MDA468 cell lines and
were analyzed via immunoblot analysis using anti-ASK1 and anti-tubulin
antibodies.
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Co-immunoprecipitation analysis was performed as previously
described [12], with slight modiﬁcations. Cells were lysed with
buffer (0.5% NP-40, 1 mM EDTA, 50 mM Tris–HCl, pH 8.0,
120 mM NaCl) and the lysates were subjected to 10 min of micro-
centrifugation at 12 000g. The soluble fraction was then incu-
bated for 2 h at 4 C with the appropriate antibodies, after which
the mixture was incubated for an additional 1 h at 4 C with pro-
tein G-coupled Sepharose beads (Amersham Pharmacia Biotech,
Uppsala). The resultant precipitates were subjected to SDS–PAGE
and analyzed via immunoblotting.
2.4. Immunoblot analysis
In brief, cell lysates were subjected to SDS–PAGE and trans-
ferred to PVDF membranes. The PVDF membranes were then
blocked with 5% non-fat milk in a washing buffer (50 mM Tris–
HCl, pH 8.0, 150 mM NaCl, 0.1% Tween 20) and incubated with
the indicated antibodies for 1 h at room temperature. The mem-
branes were subsequently washed and incubated for 1 h at room
temperature with the appropriate secondary antibodies conju-
gated with horseradish peroxidase (Amersham Pharmacia Bio-
tech). Protein bands were visualized using an enhanced
chemiluminescence system (Amersham Pharmacia Biotech).
2.5. Luciferase assay
Cells were transiently cotransfected using a microporator (Dig-
ital Bio Technology, South Korea) with a pTopﬂash and a control
pb-galactosidase report construct. After 36 h of incubation, the
cells were treated for an additional 12 h with 10 mM LiCl. Lucifer-
ase and b-galactosidase activities were measured according to the
manufacturer’s instructions (Promega, WI) using a luminometer
and a spectrophoto-meter, respectively.
2.6. Migration assay
Cell migration was evaluated using Transwell chambers sup-
plied with ﬁlters containing polycarbonate membranes (8 lm pore
size; Corning, NY). The cells were counted (1  104 cells) and then
added to the upper chambers of 24-well transwell plates in serum-
reduced media (DMEM with 0.5% FBS) and were cultured for 24 h
with DMEM media containing 5% FBS in the lower well, and motile
cells at the bottom of the ﬁlter were ﬁxed with 4% formaldehyde
and stained with 40,60-diamidino-2-phenylindole (DAPI). The num-
ber of migrating cells was quantiﬁed by counting the stained cells
under a ﬂuorescence microscope (40 objective).
2.7. Cell proliferation assay
Cell proliferation assay using Brd-uridine incorporation was
performed using the Cell Proliferation ELISA kit (Roche Molecular
Biochemicals, Rotkreuz, Switzerland) according to the manufac-
turer’s instruction. In brief, cells were seeded at a density of
10 000 cells per well, allowed to adhere for 24 h. Proliferation
was quantiﬁed 36 h post-transfection.
3. Results
3.1. ASK1 is highly expressed in less metastatic breast cancer cell lines
(MCF7, SKBR3, MDA468) rather than metastatic breast cancer cell line
(MDA231)
To determine whether ASK1 is related with breast cancer
metastasis, we examined the level of ASK1 in various breast cancercell lines. As shown in Fig. 1, ASK1 was expressed at higher levels in
non-metastatic breast cancer cell lines (MCF7, SKBR3, MDA468),
rather than metastatic breast cancer cell line (MDA231). From this
result, we knew that ASK1 is closely involved in breast cancer
metastasis.
3.2. MCF7 ASK1 siRNA cells migrate rapidly as compared to MCF7 GFP
control cells, as the result of GSK3 inhibition but not JNK or P38
inhibition
Next, to conﬁrm the relativity of ASK1 in breast cancer metasta-
sis, we manufactured MCF7 ASK1 siRNA cells and investigated cell
migration and proliferation. The migration of MCF7 ASK1 siRNA
cells was accelerated as compared with that of MCF7 GFP control
cells (Fig. 2A and C). However, cell proliferation was not signiﬁ-
cantly altered, regardless of the presence of ASK1 (Supplementary
Fig. 1). We attempted to determine which signaling disruption
caused by ASK1 knockdown provokes this increased migration
using JNK, p38, and GSK-3 inhibitors. In GSK-3 inhibitor-treated
cells, but not JNK or p38 inhibitor-treated cells, increased migra-
tion levels were detected (Fig. 2B and D). Additionally, the charac-
teristics of EMT, including the loss of E-cadherin, increased N-
cadherin and snail, one of the EMT regulators, were also noted in
MCF7 ASK1 siRNA cells (Supplementary Fig. 2). These data show
that the ASK1-mediated regulation of GSK-3 activity, but not JNK
or p38 activity, performs an important role in altering cell motility,
rather than cell proliferation.
3.3. ASK1 inhibits b-catenin activity via the regulation
of GSK-3 b activity
In order to determine whether the increased migration in MCF7
ASK1 siRNA cells is dependent on the activation of b-catenin via
the inhibition of the GSK-3 signaling pathway, we evaluated the
activity of b-catenin, a representative downstream target of GSK-
3. Indeed, b-catenin activity was increased in the MCF7 ASK1 siRNA
cells, as compared with MCF7 GFP control cells (Fig. 3A). Owing to
the aberrant upregulation of b-catenin activity under conditions of
absent ASK1 expression, we attempted to assay directly the activ-
ity of GSK-3b. As shown in Fig. 3B, the phosphorylation of Tyr 216
on GSK-3b necessary for its activation and the level of Axin, a scaf-
folding protein of the Wnt signaling pathway, were diminished in
the MCF7 ASK1 siRNA cells, as compared with those in the MCF7
GFP control cells. Because basally active GSK-3b stabilizes Axin
via phosphorylation [5–8], reduced levels of Axin are also associ-
ated with inhibited GSK-3b activity. These data imply that basal
GSK-3 kinase activity is inhibited under reduced ASK1 conditions.
As a consequence, b-catenin activity was increased. We inferred
that ASK1 modulates not only b-catenin activity but also Axin
Fig. 2. MCF7 ASK1 siRNA cells migrate rapidly, compared to MCF7 GFP control cells, as the result of GSK3 inhibition but not JNK or P38 inhibition. (A) MCF7 GFP control cells
and ASK1 siRNA cells (1  104 cells) were added to the upper chambers of 24-well transwell plates in serum-reduced media (DMEM with 0.5% FBS). MCF7 GFP control cells
and ASK1 siRNA cells were cultured with DMEMmedia containing 5% FBS in the lower well for 24 h. The migration was measured as described in Section 2. Data are reported
in terms of migrated cells. The error bars represent the means ± S.D. of two experiments. (B) MCF7 cells were added to the upper chamber of 24-well transwell plates in
serum-reduced media (DMEM with 0.5% FBS). MCF7 cells were cultured in the absence or presence of 10 mM GSK3 inhibitor (LiCl) or 25 lM JNK inhibitor (SB600125) or
10 lM P38 inhibitor (SB203580) in the lower well for 24 h and motile cells were countered. (C and D) Photograph of the cells that migrated through the transwell inserts. The
error bars represent the means ± S.D. of three experiments. *P < 0.05 compared with untreated control.
Fig. 3. ASK1 inhibits b-catenin activity via the regulation of GSK-3 activity. (A) MCF7 GFP control cells and ASK1 siRNA cells were transiently cotransfected with a pTopﬂash
and a control pb-galactosidase report construct. After 36 h of incubation, these transfectants were subsequently incubated for 12 h in the absence or presence of 10 mM LiCl.
The data are expressed in terms of relative luciferase activity (normalized to b-galactosidase activity). The error bars are expressed as the means ± S.D. of three experiments.
**P < 0.001. (B) Whole-cell extracts were prepared from MCF7 GFP control cells and ASK1 siRNA cells, and were analyzed via immunoblot analysis using anti-ASK1, anti-Axin,
anti-GSK-3b and anti-phospho-GSK3 (Tyr279/Tyr216) antibodies.
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However, the phosphorylation of Tyr 279 on GSK-3a was not al-
tered signiﬁcantly, regardless of the presence of ASK1 (Supplemen-tary Fig. 3). This result demonstrates that the increased activity of
b-catenin in the absence of ASK1 is attributable to reduced GSK-3b
activity rather than GSK-3a activity.
Fig. 5. ASK1 regulates the formation of the Axin–GSK-3b–b-catenin destruction
complex. The formation of Axin–GSK-3b–b-catenin complex was reduced in MCF7
ASK1 siRNA cells. Cell lysates were subjected to immunoprecipitation with anti-
GSK-3b antibody, and the resultant precipitates were subjected to immunoblot
analysis with the indicated antibodies. Cell lysates were also directly assessed via
immunoblot analysis with anti-b-catenin, anti-ASK1, anti-Axin and anti-GSK-3b
antibodies.
4100 K.T. Noh et al. / FEBS Letters 584 (2010) 4097–41013.4. ASK1 participates in the Wnt signaling pathway via the regulation
of GSK-3b
Next, we assessed the proﬁle of Axin–GSK-3b–b-catenin
destruction complex components under Wnt signaling conditions.
Whereas LiCl treatment (Wnt signaling mimic condition) induced a
diminished level of Axin via GSK-3b inhibition and the abnormally
launched b-catenin production caused by the reduced Axin, the
scaffolding protein of Axin–GSK-3b–b-catenin destruction complex
in the presence of ASK1 [10,13], these phenomena were not noted
under ASK1 knockdown conditions (Fig. 4). Additionally, LiCl treat-
ment also reduced the levels of ASK1, as well as Axin. According to
these results, we hypothesized that ASK1 performs a pivotal func-
tion in the formation of the Axin–GSK-3b–b-catenin destruction
complex via the regulation not only of GSK-3b activity, but also
levels of Axin, and leads to the regulation of b-catenin, the effector
protein of the Wnt signaling pathway.
3.5. ASK1 regulates the formation of Axin–GSK-3b–b-catenin
destruction complex
To evaluate our hypothesis, we evaluated this destruction
complex via a co-immunoprecipitation assay. The destruction
complex was disrupted in the MCF7 ASK1 siRNA cells, whereas
the Axin–GSK-3b–b-catenin destruction complex was basally
formed in the MCF7 GFP control cells (Fig. 5). As shown in
Figs. 4 and 5, we inferred that ASK1 is involved in the Wnt signal-
ing pathway by Axin dynamics via the regulation of GSK-3b activ-
ity. In other words, the Axin–GSK-3b–b-catenin destruction
complex was not formed, because of the inhibited GSK-3b activity
and the ASK1-mediated reduction of GSK-3b-induced Axin stabil-
ity. This means that ASK1 regulates the basal GSK-3b kinase activ-
ity critical for the formation of the Axin–GSK-3b–b-catenin
destruction complex.
4. Discussion
GSK-3b is known as a basally active kinase, and it stabilizes Axin
via subsequent phosphorylation. Next, the stabilized Axin, a scaf-
folding protein, forms a complex with GSK-3b and b-catenin, and
this complex formation is necessary for the maintenance of basalFig. 4. ASK1 activates GSK-3b and regulates Wnt signaling pathway. MCF7 GFP
control cells and ASK1 siRNA cells were incubated for 4 h in the absence or presence
of 10 mM LiCl. The cell lysates were also subjected directly to immunoblot analysis
with anti-b-catenin, anti-ASK1, anti-Axin and anti-GSK-3b antibodies.GSK-3b activity. However, the precise mechanism for the activa-
tion of GSK-3b in a basal state is not deﬁned. In this study, we have
demonstrated that the basal activity of GSK-3b, the Axin stability,
the formation of the destruction complex and the activity of b-
catenin, are regulated by ASK1 in resting cells. Therefore, we sug-
gest that ASK1 is closely correlated with the regulation of GSK-3b
basal activity.
Among various cellular processes regulated by GSK-3b, we fo-
cused on the regulation of cell motility. Previous studies have doc-
umented that b-catenin, a downstream transcription factor of GSK-
3b, promotes migration [14,15]. Recently, the regulation of EMT,
one of the processes inherent to cancer progression, was reported
to occur via the inhibition of GSK-3 [16,17]. By all accounts, GSK-3
functions as a repressor of cell motility at the basal level and pro-
tects against cancer progression. According to our results, these
GSK-3 functions might be controlled by ASK1 in the basal state.
Furthermore, we determined that ASK1 is related closely with
breast cancer metastasis. Further researches to deﬁne the mecha-
nism underlying the regulation of GSK-3 by ASK1 and to illuminate
the precise relevance of ASK1 in cancer progression are currently
underway. A more precise understanding of the interrelationship
between ASK1 and the Axin–GSK-3b–b-catenin destruction com-
plex components will provide us with insights critical to the devel-
opment of effective cancer drugs.
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